Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
40285-9 Glucose^75M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --75 minutes post dose glucose   MIN DefinitionDescription     mmol/L             CHAL   40285-9         Observation       0 Glucose 75M p Glc SerPl-sCnc       N   75M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40286-7 Glucose^105M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --105 minutes post dose glucose   MIN DefinitionDescription     mmol/L             CHAL   40286-7         Observation       0 Glucose 105M p Glc SerPl-sCnc       N   105M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40287-5 Glucose^1H post meal SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1 hour post meal   MIN DefinitionDescription     mmol/L             CHAL   40287-5         Both       0 Glucose 1h p meal SerPl-sCnc       N   1 hour; 1.0Hr; 1h p meal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 2.15               mmol/L       0
40288-3 Insulin^30M post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40288-3         Observation       0 Insulin 30M p chal SerPl-sCnc       N   30M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40289-1 Insulin^1H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40289-1         Observation       0 Insulin 1h p chal SerPl-sCnc       N   1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
4029-5 Secobarbital PrThr Urine Pt Ord     ACTIVE Secobarbital [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   4029-5         Both       0 Secobarbital Ur Ql           Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Secobarb; Seconal; UA; UR; Urn 2.73 1                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
40290-9 Insulin^1.5H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40290-9         Observation       0 Insulin 1.5h p chal SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40291-7 Insulin^2H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40291-7         Observation       0 Insulin 2h p chal SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40292-5 Insulin^2.5H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40292-5         Observation       0 Insulin 2.5h p chal SerPl-sCnc       N   2.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40293-3 Insulin^3H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge   MIN DefinitionDescription     pmol/L             CHAL   40293-3         Observation       0 Insulin 3h p chal SerPl-sCnc       N   3h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40294-1 Insulin^pre or post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE Insulin [Moles/volume] in Serum or Plasma --pre or post dose glucose   MIN DefinitionDescription     pmol/L             CHAL   40294-1         Observation       0 Insulin pre/p Glc SerPl-sCnc       N   After; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; pre/p Glc; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.15               pmol/L       0
40295-8 Triiodothyronine.free^2H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post XXX challenge   MIN DefinitionDescription     pmol/L;nmol/L             CHAL   40295-8         Observation       0 T3Free 2h p chal SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T3; T-3; T3Free; thyroid hormone; Total T3; Triodothyrne 2.7 2.15               pmol/L       0
40296-6 Xylose^post CFst SCnc Ser/Plas Pt Qn     ACTIVE Xylose [Moles/volume] in Serum or Plasma --fasting   MIN DefinitionDescription     mmol/L;nmol/L             CHAL   40296-6         Observation       0 Xylose p fast SerPl-sCnc       N   After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; D-xylose; Fast; Fasting; Level; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylose absorption test 2.7 2.15               mmol/L       0
40297-4 Somatotropin^3.5H post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40297-4         Observation       0 GH 3.5h p chal SerPl-mCnc       N   3.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL       0
40298-2 Somatotropin^pre dose cloNIDine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --pre dose cloNIDine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40298-2         Observation       0 GH pre CLN SerPl-mCnc       N   Before; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre CLN; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.7 2.15               ng/mL       0
40299-0 Somatotropin^1H post dose cloNIDine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40299-0         Observation       0 GH 1h p CLN SerPl-mCnc       N   1 hour; 1.0Hr; 1h p CLN; 60 min; 60 minutes; 60M; 60min; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL       0
403-6 Pipemidate Susc Isolate Pt Qn MLC   ACTIVE Pipemidate [Susceptibility] by Minimum lethal concentration (MLC)   MIN DefinitionDescription                   ABXBACT   403-6   MLC     Observation       0 Pipemidate Islt MLC       Y   Acipern; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biopim; Cistomid; Deblaston; Diperpen; Dokol; Faremid; Filtrax; Galusan; ID; Impresial; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Nuril; Pipeacid; Pipedac; Pipedose; Pipefort; Pipemid; Pipemidic acid; Piperamic acid; Pipram; Pipurin; Point in time; Pro-uro; QNT; Quan; Quant; Quantitative; Random; Septidron; Solupemid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tractur; Urisan; Urodene 2.19 1                       0
4030-3 Sotalol PrThr Urine Pt Ord     ACTIVE Sotalol [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   4030-3         Both       0 Sotalol Ur Ql           Beta-cardone; Betapace; Betudes; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Solalex; Sotacor; UA; UR; Urn 2.56 1                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
40300-6 Somatotropin^1.5H post dose cloNIDine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40300-6         Observation       0 GH 1.5h p CLN SerPl-mCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p CLN; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL       0
40301-4 Somatotropin^2H post dose cloNIDine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40301-4         Observation       0 GH 2h p CLN SerPl-mCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p CLN; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL       0
40302-2 Somatotropin^pre dose arginine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --pre dose arginine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40302-2         Observation       0 GH pre Arg SerPl-mCnc       N   Arg; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Arg; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.7 2.15               ng/mL       0
40303-0 Somatotropin^1H post dose arginine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40303-0         Observation       0 GH 1h p Arg SerPl-mCnc       N   1 hour; 1.0Hr; 1h p Arg; 60 min; 60 minutes; 60M; 60min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL       0
40304-8 Somatotropin^1.5H post dose arginine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40304-8         Both       0 GH 1.5h p Arg SerPl-mCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Arg; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL     Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. 0
40305-5 Somatotropin^2H post dose arginine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40305-5         Both       0 GH 2h p Arg SerPl-mCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 2.15               ng/mL     Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. 0
40306-3 Somatotropin^3H post dose arginine MCnc Ser/Plas Pt Qn     ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose arginine   MIN DefinitionDescription     ug/L;ng/mL             CHAL   40306-3         Observation       0 GH 3h p Arg SerPl-mCnc       N   3h p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.7 2.15               ng/mL       0
104,672 results found